Where does Lennham Pharmaceuticals, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lennham Pharmaceuticals, Inc. ranks #22,896 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lennham Pharmaceuticals, Inc. hold?

Lennham Pharmaceuticals, Inc. holds 12 US utility patents granted between 2020 and 2025, spanning 4 technology areas.

What is Lennham Pharmaceuticals, Inc.'s Innovation Score?

Lennham Pharmaceuticals, Inc. has an Innovation Score of 40.2 out of 100 (top 36% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Lennham Pharmaceuticals, Inc. focus on?

Lennham Pharmaceuticals, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 8 patents, ranking #2,696 of 7,163 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

Is Lennham Pharmaceuticals, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Lennham Pharmaceuticals, Inc..

What does claim depth mean for Lennham Pharmaceuticals, Inc.'s patents?

Lennham Pharmaceuticals, Inc.'s patents average 21.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lennham Pharmaceuticals, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Lennham Pharmaceuticals, Inc.

USPTO PatentsView assignee record - 12 granted patents across 4 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lennham ranks #22,896 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 4 technology areas.

#22,896
of 49,997 US assignees by volume: Top 36%
by Innovation Score (40.2/100): 21.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R22896 · US Corporation #22,896 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 12 grants
MID-PACK #22,896/49,997
PHOTO-FINISH Lalabu
CPC-NARROW A61K · 4 areas
INNOV-PAR 40.2/100
CLAIMS-DENSE 21.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Lalabu LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lennham’s 40.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (22%) Velocity 11.7 pts (29%) Breadth 7.1 pts (18%) Claim depth 12.6 pts (31%)

Qualcomm Incorporated · highest

85
Lennham Pharmaceutic… · this assignee

40
3D Lighting… · lowest

7

What this shows Lennham's Innovation Score is 40.2/100 (top 36% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lennham?

Each dot is one of Lennham’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lennham’s own 21.0 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lennham vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lennham's grants concentrate

Lennham Pharmaceuticals, Inc. is a focused PatentsView assignee: 4 CPC subclasses with 66.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2024. By volume, Lennham sits between Lalabu LLC and Lin Engineering, Inc..

Lennham's three-year grant acceleration

Lennham Pharmaceuticals, Inc. shows 7 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Lalabu

12
Lancaster Univers…

12
Ledup Manufacturi…

12
Lenbrook Industri…

12
Lifeline Systems

12
Light

12
Light Line Medical

12
Lin Engineering

12
Lennham Pharmaceu… ◀

12

What this shows Lennham holds 12 patents at rank #22,906, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lennham

By rank, the assignees closest to #22,906 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Lennham's primary technology class.

Lennham's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 36% higher than 64% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Lennham Pharmaceuticals, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	2	16.7%
2021	2	16.7%
2022	3	25.0%
2023	3	25.0%
2024	1	8.3%
2025partial year	1	8.3%

Which technologies does Lennham Pharmaceuticals, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 4

A23V - Indexing Scheme Relating TO Foods, Foodstuffs OR Non-alcoholic Beverages AND Lactic OR Propionic Acid Bacteria Used IN Foodstuffs OR Food Preparation 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lennham Pharmaceuticals, Inc.'s patent record in context - here's where to go next.

Lennham Pharmaceuticals, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 66.7% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #22,896 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lennham Pharmaceuticals, Inc. against Lalabu LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.